Occudo Quantitative Strategies’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,916
| Closed | -$17.1K | – | 1067 |
|
|
2023
Q3 | $17.1K | Sell |
1,916
-8,094
| -81% | -$72.3K | ﹤0.01% | 925 |
|
|
2023
Q2 | $86.4K | Hold |
10,010
| – | – | 0.01% | 938 |
|
|
2023
Q1 | $106K | Sell |
10,010
-6,398
| -39% | -$67.5K | 0.01% | 815 |
|
|
2022
Q4 | $556K | Sell |
16,408
-4,399
| -21% | -$149K | 0.06% | 470 |
|
|
2022
Q3 | $999K | Buy |
20,807
+1,441
| +7% | +$69.2K | 0.08% | 399 |
|
|
2022
Q2 | $1.1M | Buy |
19,366
+12,617
| +187% | +$719K | 0.09% | 354 |
|
|
2022
Q1 | $546K | Buy |
6,749
+4,560
| +208% | +$369K | 0.05% | 613 |
|
|
2021
Q4 | $444K | Sell |
2,189
-328
| -13% | -$66.5K | 0.04% | 655 |
|
|
2021
Q3 | $678K | Buy |
2,517
+1,843
| +273% | +$496K | 0.08% | 423 |
|
|
2021
Q2 | $174K | Buy |
+674
| New | +$174K | 0.03% | 737 |
|
|
2021
Q1 | – | Sell |
-1,576
| Closed | -$402K | – | 871 |
|
|
2020
Q4 | $402K | Buy |
+1,576
| New | +$402K | 0.13% | 318 |
|